Uncovering the therapeutic potential of anti-tuberculoid agent Isoniazid in a model of microbial-driven Crohn’s disease - Quiz - MDSpire

Uncovering the therapeutic potential of anti-tuberculoid agent Isoniazid in a model of microbial-driven Crohn’s disease

  • By

  • Matthew Stephens

  • Keith Keane

  • Simon Roizes

  • Manon Defaye

  • Christophe Altier

  • Pierre-Yves von der Weid

  • February 23, 2025

  • 0 min

Share

Original Source(s)

Uncovering the therapeutic potential of anti-tuberculoid agent Isoniazid in a model of microbial-driven Crohn’s disease

  • by Matthew Stephens, Keith Keane, Simon Roizes, Manon Defaye, Christophe Altier, Pierre-Yves von der Weid

  • February 23, 2025

Related Content

GLP-1 and GLP-2 as intestinal reparative therapies in inflammatory bowel disease: mechanisms, translation, and clinical opportunity

The innovation trap: How pharma weaponizes a word to extend monopolies

Case Report: Bilateral panuveitis with serous ciliary body and choroidal detachment associated with ulcerative colitis